ACM Research (“ACMR”) released an 8K on Friday with very promising implications for shareholders. The company’s shares trade at a dramatic discount to the shares of its Chineselisted subsidiary (“ACMS”) which trades on the Shanghai STAR exchange, and market participants have long discussed ways in which this discount could narrow. Our view is that a dual listing in Hong Kong would be an effective way of narrowing the discount, and is the most preferable solution. Friday’s 8K represented a step in that direction, as the company announced that its Chinese subsidiary “ACM Shanghai issued an announcement” to the Shanghai Stock Exchange “that ACM Shanghai is proposing to issue overseas listed shares and apply for listing on The Stock Exchange of Hong Kong Limited (the “H Share Listing”).”
ACMR, the U.S.-listed ticker of ACM Research, Inc., trades at a massive discount to ACMS, its Chinese-listed subsidiary ACM Research (Shanghai), Inc. The market capitalization of ACMR is $3.6b. It owns 74% of ACMS, with the remaining 26% of ACMS owned by Chinese shareholders. ACMS is being valued at $11.1b based on the value of its Chinese shares in the Chinese stock market currently, rendering the value of ACMR’s 74% stake to be $8.1b. So the U.S. stock market is valuing ACMR’s market valuation at $3.6b, while it owns paper worth $8.1b. This shareholding is fully transactable – in fact, on February 6, 2026, ACMR sold a token 1% of its shareholdings at ¥160 per ACMS share for proceeds of $111m. The transaction price of ¥160 was approximately a 10% discount to where ACMS shares were trading at the time.
For our full note, please click here.




Add New Comment